135 related articles for article (PubMed ID: 25769452)
1. Quantification of autoantibodies to plasminogen in plasma of patients with cancer.
Goufman EI; Iakovlev VN; Tikhonova NB; Lokshin AE
Cancer Biomark; 2015; 15(3):281-7. PubMed ID: 25769452
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to plasminogen and their role in tumor diseases.
Goufman EI; Yakovlev VN; Tikhonova NB; Aisina RB; Yarygin KN; Mukhametova LI; Gershkovich KB; Gulin DA
Bull Exp Biol Med; 2015 Feb; 158(4):493-6. PubMed ID: 25708333
[TBL] [Abstract][Full Text] [Related]
3. Increased Blood Concentration of IgG Degradation Products in Prostate Cancer.
Goufman IE; Yakovlev VN; Tikhonova NB; Matevosyan KS; Boltovskaya MN; Aisina RB; Mukhametova LI; Gershkovich KB
Bull Exp Biol Med; 2019 Mar; 166(5):651-655. PubMed ID: 30903509
[TBL] [Abstract][Full Text] [Related]
4. PO-17 - Identification of IgG bound to plasminogen in oncologic diseases.
Iakovlev VN; Goufman EI; Tikhonova NB; Aisina RB; Mukhametova LI; Gershkovich KB
Thromb Res; 2016 Apr; 140 Suppl 1():S182. PubMed ID: 27161704
[TBL] [Abstract][Full Text] [Related]
5. Plasma vascular endothelial growth factors A and C in patients undergoing prostatic biopsy and TURP for suspected prostatic neoplasia.
Singh A; Gautam KA; Dalela D; Sankhwar S; Natu S; Sankhwar P; Srivastava A
Asian Pac J Cancer Prev; 2013; 14(3):2053-8. PubMed ID: 23679318
[TBL] [Abstract][Full Text] [Related]
6. Effects of oxygen on the antigenic landscape of prostate cancer cells.
Ma T; Schreiber CA; Knutson GJ; Khattouti AE; Sakiyama MJ; Hassan M; Charlesworth MC; Madden BJ; Zhou X; Vuk-Pavlović S; Gomez CR
BMC Res Notes; 2015 Nov; 8():687. PubMed ID: 26581192
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer.
Li J; Dai L; Lei N; Xing M; Li P; Luo C; Casiano CA; Zhang JY
Oncotarget; 2016 Jul; 7(28):43546-43556. PubMed ID: 27286458
[TBL] [Abstract][Full Text] [Related]
8. Anti-plasminogen autoantibodies from plasma of patients with systemic lupus erythematosus having anti-phospholipid antibody syndrome: isolation and some immunochemical properties.
Kozmin LD; Shirokova IE; Lisitsina TA; Popkova TV; Reschetnyak TM; Belenkiy AG; Martynov AI; Bliznukov OP
Biochemistry (Mosc); 2003 Mar; 68(3):339-45. PubMed ID: 12733977
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody signatures as biomarkers to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate specific antigen.
O'Rourke DJ; DiJohnson DA; Caiazzo RJ; Nelson JC; Ure D; O'Leary MP; Richie JP; Liu BC
Clin Chim Acta; 2012 Mar; 413(5-6):561-7. PubMed ID: 22146597
[TBL] [Abstract][Full Text] [Related]
10. The malignancy index is a robust predictor of prostate cancer.
Serafin AM; Chinhengo A; Akudugu JM
Discov Med; 2020; 29(158):181-189. PubMed ID: 33007193
[TBL] [Abstract][Full Text] [Related]
11. Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens.
Dai L; Li J; Ortega R; Qian W; Casiano CA; Zhang JY
J Immunol Res; 2014; 2014():827827. PubMed ID: 24860838
[TBL] [Abstract][Full Text] [Related]
12. Alpha 2HS-glycoprotein, a tumor-associated antigen (TAA) detected in Mexican patients with early-stage breast cancer.
Fernández-Grijalva AL; Aguilar-Lemarroy A; Jave-Suarez LF; Gutiérrez-Ortega A; Godinez-Melgoza PA; Herrera-Rodríguez SE; Mariscal-Ramírez I; Martínez-Velázquez M; Gawinowicz MA; Martínez-Silva MG; Cruz-Ramos JA; Hernández-Gutiérrez R
J Proteomics; 2015 Jan; 112():301-12. PubMed ID: 25106788
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study.
Rehman I; Azzouzi AR; Catto JW; Allen S; Cross SS; Feeley K; Meuth M; Hamdy FC
Urology; 2004 Dec; 64(6):1238-43. PubMed ID: 15596215
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers.
Ummanni R; Duscharla D; Barett C; Venz S; Schlomm T; Heinzer H; Walther R; Bokemeyer C; Brümmendorf TH; Murthy PV; Balabanov S
J Proteomics; 2015 Apr; 119():218-29. PubMed ID: 25724726
[TBL] [Abstract][Full Text] [Related]
15. Expression of soluble urokinase plasminogen activator receptor may be related to outcome in prostate cancer patients.
McCabe NP; Angwafo FF; Zaher A; Selman SH; Kouinche A; Jankun J
Oncol Rep; 2000; 7(4):879-82. PubMed ID: 10854562
[TBL] [Abstract][Full Text] [Related]
16. Presence of PSA auto-antibodies in men with prostate abnormalities (prostate cancer/benign prostatic hyperplasia/prostatitis).
Lokant MT; Naz RK
Andrologia; 2015 Apr; 47(3):328-32. PubMed ID: 24620795
[TBL] [Abstract][Full Text] [Related]
17. Plasma Sarcosine Measured by Gas Chromatography-Mass Spectrometry Distinguishes Prostatic Intraepithelial Neoplasia and Prostate Cancer from Benign Prostate Hyperplasia.
Markin PA; Brito A; Moskaleva N; Fodor M; Lartsova EV; Shpot YV; Lerner YV; Mikhajlov VY; Potoldykova NV; Enikeev DV; Lyundup AV; Appolonova SA
Lab Med; 2020 Nov; 51(6):566-573. PubMed ID: 32161964
[TBL] [Abstract][Full Text] [Related]
18. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.
Adam BL; Qu Y; Davis JW; Ward MD; Clements MA; Cazares LH; Semmes OJ; Schellhammer PF; Yasui Y; Feng Z; Wright GL
Cancer Res; 2002 Jul; 62(13):3609-14. PubMed ID: 12097261
[TBL] [Abstract][Full Text] [Related]
19. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
[TBL] [Abstract][Full Text] [Related]
20. Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort.
Adeola HA; Smith M; Kaestner L; Blackburn JM; Zerbini LF
Oncotarget; 2016 Mar; 7(12):13945-64. PubMed ID: 26885621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
